Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) hosted the “Breast Cancer Update Conference 2024” on June 15th and 16th, gathering leading experts, researchers, and healthcare professionals from India and abroad to discuss groundbreaking advancements in breast cancer research.
In a press statement on Monday, the healthcare provider said that the event highlighted critical findings from the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and San Antonio Breast Cancer Symposium (SABCS).
Under the patronage of Chairman Rakesh Chopra, the conference featured expert-led sessions on emerging therapies, precision medicine, and patient-centred care. Attendees participated in panel discussions and interactive workshops focusing on early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and advanced treatment options such as immunotherapy and precision medicine.
Renowned oncologists presented significant findings from recent studies and trials on targeted therapies, immunotherapy treatments like Pembrolizumab, cyclin inhibitor tablets, and new surgical procedures and radiation techniques. These presentations offered valuable insights into innovative treatments and patient care strategies.
D C Doval, Chair of Medical Oncology & Chief of Breast & Thoracic Services at RGCIRC and Organising Chairman emphasised the importance of the conference for sharing knowledge and driving advancements in breast cancer treatment. "The Breast Cancer Update Conference 2024 provided an invaluable opportunity for professionals to learn from each other and stay abreast of the latest research and clinical practices worldwide. Our goal is to advance our collective efforts in breast cancer care and improve patient outcomes. Together, we can make significant strides in the fight against breast cancer."
Pankaj Goyal, Senior Consultant, Medical Oncology at RGCIRC, highlighted the event's success, stating, “Our goal is to ensure that the latest advancements in breast cancer research are rapidly translated into clinical practice. This conference has been instrumental in bridging the gap between research and patient care, and we are committed to continuing this momentum.”
(Prof) Sudhir Kumar Rawal, Medical Director, noted the conference's role in bridging the gap between research and patient care, while Dr. Vineet Talwar, Director of Medical Oncology, expressed optimism about its impact. Dr. A.K. Dewan, Director, of Surgical Oncology, emphasised that the Breast Cancer Update Conference 2024 represents RGCIRC’s ongoing commitment to addressing the complexities of breast cancer.
